United Therapeutics Corporation Reports First Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
United Therapeutics (UTHR) Tops Q1 EPS by 55c, Revenues Beat
May 5, 2021 6:05 AM EDTUnited Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $3.49, $0.55 better than the analyst estimate of $2.94. Revenue for the quarter came in at $379.1 million versus the consensus estimate of $368.95 million.
"2021 is already a historic year for United Therapeutics, with the recent FDA approval and launch... More
